StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) stock

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3083% above fair value
$272.70−6.00 (-2.15%)

Close on Nov 18, 2026Market cap $656.47BP/E 41.4Yield 1.88%

Johnson & Johnson operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2014 it was $21.59B, up 31.6% from the year before. The highest annual figure on record is $21.59B in fiscal 2014.

Annual operating income

PeriodPeriod endValueChange
FY2014Dec 28, 2014$21.59B+31.6%
FY2013Dec 29, 2013$16.41B+9.7%
FY2012Dec 30, 2012$14.96B+8.6%
FY2011Jan 1, 2012$13.77B-22.2%
FY2010Jan 2, 2011$17.70B+6.7%
FY2009Jan 3, 2010$16.58B–

More Johnson & Johnson figures

See a number that looks wrong?